Attenuated Effects of Topical Empagliflozin on Imiquimod-induced Model of Psoriasis in Mice
Empagliflozin is a sodium-glucose cotransporter inhibitor (SGLT2) that drops blood glucose levels by inhibiting glucose reabsorption and encouraging glucose excretion. Other benefits of empagliflozin include cardiovascular protection, lowering uric acid levels, and reducing liver damage brought on b...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
University of Brawijaya
2024-09-01
|
| Edice: | Journal of Tropical Life Science |
| Témata: | |
| On-line přístup: | https://jtrolis.ub.ac.id/index.php/jtrolis/article/view/3099 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|